BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19738030)

  • 1. Wild-type FOXP3 is selectively active in CD4+CD25(hi) regulatory T cells of healthy female carriers of different FOXP3 mutations.
    Di Nunzio S; Cecconi M; Passerini L; McMurchy AN; Baron U; Turbachova I; Vignola S; Valencic E; Tommasini A; Junker A; Cazzola G; Olek S; Levings MK; Perroni L; Roncarolo MG; Bacchetta R
    Blood; 2009 Nov; 114(19):4138-41. PubMed ID: 19738030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point mutants of forkhead box P3 that cause immune dysregulation, polyendocrinopathy, enteropathy, X-linked have diverse abilities to reprogram T cells into regulatory T cells.
    McMurchy AN; Gillies J; Allan SE; Passerini L; Gambineri E; Roncarolo MG; Bacchetta R; Levings MK
    J Allergy Clin Immunol; 2010 Dec; 126(6):1242-51. PubMed ID: 21036387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of FOXP3-negative regulatory T-like (CD4(+)CD25(+)CD127(low)) cells in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.
    Otsubo K; Kanegane H; Kamachi Y; Kobayashi I; Tsuge I; Imaizumi M; Sasahara Y; Hayakawa A; Nozu K; Iijima K; Ito S; Horikawa R; Nagai Y; Takatsu K; Mori H; Ochs HD; Miyawaki T
    Clin Immunol; 2011 Oct; 141(1):111-20. PubMed ID: 21802372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective regulatory and effector T cell functions in patients with FOXP3 mutations.
    Bacchetta R; Passerini L; Gambineri E; Dai M; Allan SE; Perroni L; Dagna-Bricarelli F; Sartirana C; Matthes-Martin S; Lawitschka A; Azzari C; Ziegler SF; Levings MK; Roncarolo MG
    J Clin Invest; 2006 Jun; 116(6):1713-22. PubMed ID: 16741580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional type 1 regulatory T cells develop regardless of FOXP3 mutations in patients with IPEX syndrome.
    Passerini L; Di Nunzio S; Gregori S; Gambineri E; Cecconi M; Seidel MG; Cazzola G; Perroni L; Tommasini A; Vignola S; Guidi L; Roncarolo MG; Bacchetta R
    Eur J Immunol; 2011 Apr; 41(4):1120-31. PubMed ID: 21400500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe FOXP3+ and naïve T lymphopenia in a non-IPEX form of autoimmune enteropathy combined with an immunodeficiency.
    Zuber J; Viguier M; Lemaitre F; Senée V; Patey N; Elain G; Geissmann F; Fakhouri F; Ferradini L; Julier C; Bandeira A
    Gastroenterology; 2007 May; 132(5):1694-704. PubMed ID: 17484867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development.
    Gavin MA; Torgerson TR; Houston E; DeRoos P; Ho WY; Stray-Pedersen A; Ocheltree EL; Greenberg PD; Ochs HD; Rudensky AY
    Proc Natl Acad Sci U S A; 2006 Apr; 103(17):6659-64. PubMed ID: 16617117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic mechanisms of regulation of Foxp3 expression.
    Lal G; Bromberg JS
    Blood; 2009 Oct; 114(18):3727-35. PubMed ID: 19641188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resting and Activated Natural Tregs Decrease in the Peripheral Blood of Patients with Atherosclerosis.
    Yazdani M; Khosropanah S; Hosseini A; Doroudchi M
    Iran J Immunol; 2016 Dec; 13(4):249-262. PubMed ID: 27999237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Girl with IPEX syndrome with low expression of Foxp3].
    Horiuchi S; Ishiguro A; Nakagawa T; Shoji K; Nagai A; Arai K; Horikawa R; Kawai T; Watanabe N; Onodera M
    Nihon Rinsho Meneki Gakkai Kaishi; 2012; 35(6):526-32. PubMed ID: 23291488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foxp3 regulates human natural CD4+CD25+ regulatory T-cell-mediated suppression of xenogeneic response.
    Sun L; Yi S; O'Connell PJ
    Xenotransplantation; 2010; 17(2):121-30. PubMed ID: 20522244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IPEX and the role of Foxp3 in the development and function of human Tregs.
    Le Bras S; Geha RS
    J Clin Invest; 2006 Jun; 116(6):1473-5. PubMed ID: 16741571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome.
    Uzel G; Sampaio EP; Lawrence MG; Hsu AP; Hackett M; Dorsey MJ; Noel RJ; Verbsky JW; Freeman AF; Janssen E; Bonilla FA; Pechacek J; Chandrasekaran P; Browne SK; Agharahimi A; Gharib AM; Mannurita SC; Yim JJ; Gambineri E; Torgerson T; Tran DQ; Milner JD; Holland SM
    J Allergy Clin Immunol; 2013 Jun; 131(6):1611-23. PubMed ID: 23534974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Mutation in the Transcription Factor Foxp3 Drives T Helper 2 Effector Function in Regulatory T Cells.
    Van Gool F; Nguyen MLT; Mumbach MR; Satpathy AT; Rosenthal WL; Giacometti S; Le DT; Liu W; Brusko TM; Anderson MS; Rudensky AY; Marson A; Chang HY; Bluestone JA
    Immunity; 2019 Feb; 50(2):362-377.e6. PubMed ID: 30709738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune reconstitution and recovery of FOXP3 (forkhead box P3)-expressing T cells after transplantation for IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome.
    Zhan H; Sinclair J; Adams S; Cale CM; Murch S; Perroni L; Davies G; Amrolia P; Qasim W
    Pediatrics; 2008 Apr; 121(4):e998-1002. PubMed ID: 18316354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells.
    Aarts-Riemens T; Emmelot ME; Verdonck LF; Mutis T
    Eur J Immunol; 2008 May; 38(5):1381-90. PubMed ID: 18412171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
    Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
    J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic lymphocytic leukaemia cells drive the global CD4+ T cell repertoire towards a regulatory phenotype and leads to the accumulation of CD4+ forkhead box P3+ T cells.
    Piper KP; Karanth M; McLarnon A; Kalk E; Khan N; Murray J; Pratt G; Moss PA
    Clin Exp Immunol; 2011 Nov; 166(2):154-63. PubMed ID: 21985361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A novel missense mutation of FOXP3 causes immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome in a Chinese child].
    An YF; Zhao XD; Xu F; Yang XQ
    Zhonghua Er Ke Za Zhi; 2009 Nov; 47(11):824-8. PubMed ID: 20078992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combination of cyclophosphamide and interleukin-2 allows CD4+ T cells converted to Tregs to control scurfy syndrome.
    Delville M; Bellier F; Leon J; Klifa R; Lizot S; Vinçon H; Sobrino S; Thouenon R; Marchal A; Garrigue A; Olivré J; Charbonnier S; Lagresle-Peyrou C; Amendola M; Schambach A; Gross D; Lamarthée B; Benoist C; Zuber J; André I; Cavazzana M; Six E
    Blood; 2021 Apr; 137(17):2326-2336. PubMed ID: 33545713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.